VOR — VOR BIOPHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 108 SEC-registered investment managers reported holding VOR (VOR BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $878.24M across 47.75M shares. That is +10.3% by share count (+3.97M shares) versus the previous quarter, while reported value moved +14.6%. Ownership is concentrated: the five largest holders account for 44.5% of reported value and the top ten for 66.9%.
Compared with the prior quarter, 44 opened new positions, 36 added to existing stakes, 19 trimmed, 18 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of VOR BIOPHARMA INC (VOR) include Fidelity Management & Research (FMR), TCG Crossover Management, LLC, FCPM III SERVICES B.V., ranked by reported 13F value among the 232 institutional holders on this page.
VOR is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 98 | 22.13M | $422.97M | +17.0% |
| Q2 2026 | 108 | 47.75M | $878.24M | +10.3% |
| Q1 2026 | 82 | 40.67M | $720.85M | +20.8% |
| Q4 2025 | 57 | 25.36M | $329.53M | +291.9% |
| Q3 2025 | 42 | 4.38M | $213.30M | -93.8% |
| Q2 2025 | 40 | 59.00M | $94.98M | -4.3% |
| Q1 2025 | 45 | 60.14M | $43.15M | +0.3% |
| Q4 2024 | 47 | 60.61M | $67.28M | +36.2% |
Over the 8 quarters shown, institutional share counts decreased 63% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+291.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.76M | $128.96M | 0.01% | Add | |
| 3.31M | $63.09M | 0.00% | Reduce | |
| 2.04M | $38.84M | 0.00% | Reduce | |
| 1.97M | $37.58M | 0.00% | Add | |
| 979.89K | $18.70M | 0.00% | Reduce | |
| 931.64K | $17.78M | 0.82% | Add | |
| 760.22K | $14.51M | 0.02% | New | |
| 721.55K | $13.77M | 1.32% | Add | |
| 620.93K | $11.85M | 5.16% | Reduce | |
| 583.67K | $11.14M | 0.01% | Add | |
| 560.72K | $10.70M | 0.02% | Add | |
| 550.36K | $10.50M | 1.19% | New | |
| 425.74K | $8.57M | 0.00% | New | |
| 333.31K | $6.36M | 0.00% | Reduce | |
| 277.06K | $5.29M | 0.00% | Reduce | |
| 124.20K | $2.37M | 0.02% | Add | |
| 101.02K | $1.93M | 0.00% | Add | |
| 97.56K | $1.86M | 0.00% | Hold | |
| 90.84K | $1.73M | 0.00% | Reduce | |
| 78.37K | $1.50M | 0.01% | Add | |
| 73.28K | $1.40M | 0.00% | Add | |
| 56.99K | $1.09M | 0.00% | Reduce | |
| 53.73K | $1.03M | 0.14% | Hold | |
| 47.40K | $904.39K | 0.00% | New | |
| 47.38K | $904.05K | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.67M | $96.50M | 2.76% | New | |
| 5.40M | $96.43M | 1.02% | Hold | |
| 4.12M | $73.45M | 10.17% | Add | |
| 3.04M | $54.26M | 2.02% | Add | |
| 2.54M | $45.38M | 1.17% | Hold | |
| 1.93M | $34.34M | 2.64% | Add | |
| 1.75M | $31.22M | 7.17% | Add | |
| 1.75M | $31.22M | 0.64% | Hold | |
| 1.54M | $27.47M | 0.00% | Reduce | |
| 1.43M | $25.57M | 0.00% | New | |
| 1.15M | $20.57M | 0.03% | New | |
| 1.12M | $19.95M | 0.00% | Add | |
| 999.97K | $17.84M | 8.28% | Hold | |
| 794.76K | $14.18M | 0.00% | Add | |
| 750.00K | $13.38M | 0.71% | Add | |
| 700.00K | $12.49M | 5.12% | New | |
| 555.70K | $9.91M | 0.25% | New | |
| 488.37K | $8.71M | 0.00% | Add | |
| 466.77K | $8.33M | 0.32% | New | |
| 342.57K | $6.11M | 0.00% | Add | |
| 326.17K | $5.82M | 0.30% | New | |
| 321.92K | $5.74M | 0.95% | Reduce | |
| 318.67K | $5.69M | 0.63% | Hold | |
| 314.54K | $5.59M | 3.52% | New | |
| 261.89K | $4.67M | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.40M | $70.70M | 0.72% | Add | |
| 3.62M | $47.31M | 6.20% | Add | |
| 2.54M | $33.27M | 0.89% | New | |
| 2.53M | $33.04M | 0.00% | Add | |
| 1.94M | $25.42M | 1.26% | Add | |
| 1.75M | $22.89M | 0.58% | New | |
| 1.37M | $17.92M | 5.81% | New | |
| 999.97K | $13.08M | 7.67% | New | |
| 770.25K | $10.07M | 0.00% | Add | |
| 925.07K | $9.96M | 0.94% | New | |
| 465.64K | $6.09M | 0.00% | Add | |
| 410.42K | $5.37M | 1.07% | New | |
| 317.24K | $4.15M | 0.29% | New | |
| 292.12K | $3.82M | 0.00% | Add | |
| 231.00K | $3.02M | 1.45% | New | |
| 224.53K | $2.94M | 0.00% | Add | |
| 224.53K | $2.94M | 0.00% | Add | |
| 185.81K | $2.43M | 0.00% | Add | |
| 167.67K | $2.19M | 0.02% | New | |
| 163.06K | $2.13M | 0.00% | New | |
| 145.64K | $1.90M | 0.00% | Add | |
| 100.00K | $1.31M | 0.09% | New | |
| 91.05K | $1.19M | 0.00% | Add | |
| 85.00K | $1.11M | 0.01% | Reduce | |
| 53.73K | $702.82K | 0.13% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.98M | $96.58M | 1.19% | Reduce | |
| 499.97K | $24.36M | 1.37% | New | |
| 418.80K | $20.40M | 0.03% | Add | |
| 379.64K | $18.50M | 3.70% | New | |
| 236.51K | $11.52M | 0.00% | Reduce | |
| 110.17K | $5.37M | 1.80% | New | |
| 105.19K | $5.12M | 0.00% | Reduce | |
| 96.40K | $4.70M | 0.05% | Reduce | |
| 75.91K | $3.70M | 0.00% | Reduce | |
| 53.80K | $2.62M | 0.47% | New | |
| 53.73K | $2.62M | 0.52% | Reduce | |
| 50.00K | $2.44M | 0.09% | New | |
| 34.53K | $1.68M | 0.00% | Reduce | |
| 27.39K | $1.33M | 0.00% | Reduce | |
| 27.36K | $1.33M | 0.01% | New | |
| 25.40K | $1.24M | 0.69% | Reduce | |
| 24.76K | $1.21M | 0.00% | Reduce | |
| 24.76K | $1.21M | 0.00% | New | |
| 21.25K | $1.04M | 0.01% | New | |
| 21.25K | $1.04M | 0.15% | New | |
| 16.75K | $816.21K | 0.00% | Reduce | |
| 15.79K | $769.09K | 0.00% | Reduce | |
| 14.60K | $711.31K | 0.00% | Reduce | |
| 9.05K | $441.11K | 0.00% | Reduce | |
| 8.10K | $395.00K | 0.02% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 39.65M | $64.23M | 1.08% | Hold | |
| 6.36M | $10.31M | 3.96% | Hold | |
| 2.09M | $3.39M | 0.00% | Reduce | |
| 1.92M | $3.10M | 0.00% | Reduce | |
| 1.53M | $2.48M | 0.00% | Add | |
| 1.41M | $2.28M | 0.03% | Add | |
| 756.90K | $1.23M | 0.00% | New | |
| 1.07M | $1.14M | 0.34% | Hold | |
| 508.02K | $822.99K | 0.53% | Hold | |
| 474.57K | $768.00K | 0.01% | New | |
| 468.11K | $758.34K | 0.00% | Reduce | |
| 435.56K | $705.77K | 0.00% | Reduce | |
| 403.86K | $654.25K | 0.16% | New | |
| 374.76K | $607.12K | 0.00% | Reduce | |
| 275.91K | $447.00K | 0.02% | New | |
| 180.79K | $292.88K | 0.00% | Add | |
| 169.64K | $274.81K | 0.00% | Add | |
| 115.93K | $187.81K | 0.00% | Hold | |
| 110.00K | $178.20K | 0.00% | Reduce | |
| 94.39K | $152.92K | 0.02% | New | |
| 91.91K | $148.89K | 0.02% | Hold | |
| 87.48K | $141.73K | 0.00% | New | |
| 72.42K | $117.32K | 0.00% | Reduce | |
| 59.50K | $96.39K | 0.00% | Reduce | |
| 55.55K | $90.00K | 0.00% | Hold |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.06M sh · $19.56M
- Nantahala Capital Management, LLC 845.00K sh · $15.56M
- ADAR1 Capital Management, LLC 680.63K sh · $12.53M
- NAN FUNG TRINITY (HK) Ltd 646.55K sh · $11.90M
- Woodline Partners LP 379.72K sh · $6.99M
- VANGUARD PORTFOLIO MANAGEMENT LLC 340.36K sh · $6.27M
- Eversept Partners, LP 149.68K sh · $2.76M
- Sixth Street Partners Management Company, L.P. 121.40K sh · $2.23M
- BNY Mellon 97.72K sh · $1.80M
- Nuveen, LLC 94.81K sh · $1.75M
- XTX Topco Ltd 82.64K sh · $1.52M
- RHUMBLINE ADVISERS 57.53K sh · $1.06M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 1.12M sh · $19.95M
- Laurion Capital Management LP sold 318.67K sh · $5.69M
- Propel Bio Management, LLC sold 314.54K sh · $5.59M
- Quadrature Capital Ltd sold 76.63K sh · $1.37M
- JANE STREET GROUP, LLC sold 75.89K sh · $1.35M
- Simplify Asset Management Inc. sold 53.51K sh · $954.62K
- Brevan Howard Capital Management LP sold 42.22K sh · $753.15K
- Irenic Capital Management LP sold 32.66K sh · $582.71K
- Bollard Group LLC sold 23.99K sh · $428.00K
- AXQ CAPITAL, LP sold 15.02K sh · $267.94K
- INDEPENDENT FINANCIAL GROUP, LLC sold 13.97K sh · $249.31K
- WINTON GROUP Ltd sold 11.87K sh · $211.76K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 6.76M | 4.93M | 1.54M | 2.53M | 236.51K | 2.09M | 6.42M | 6.42M | 7.07M | 7.08M | 7.61M | 7.62M | 7.65M | — | — | — | — | — | — | — |
| BlackRock Inc | 3.31M | 3.47M | 794.76K | 465.64K | 34.53K | 374.76K | 484.51K | 488.36K | 487.65K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.04M | 2.08M | 1.43M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.97M | — | 1.12M | 91.05K | 9.05K | 115.93K | 115.93K | 115.93K | 115.93K | 115.93K | 657.71K | 608.01K | 605.91K | — | — | — | — | — | — | — |
| Geode Capital Management | 979.89K | 1.06M | 342.57K | 185.81K | 27.39K | 435.56K | 438.01K | 422.14K | 422.14K | 424.83K | 841.21K | 794.06K | 756.35K | — | — | 166.76K | — | — | — | — |
| Nantahala Capital Management, LLC | 931.64K | 845.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 760.22K | — | — | — | — | — | 1.99K | 3.04K | 3.76K | 3.60K | — | — | — | — | — | — | — | — | — | — |
| NAN FUNG TRINITY (HK) Ltd | 721.55K | 646.55K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NEXTBio Capital Management LP | 620.93K | 889.16K | 999.97K | 999.97K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 583.67K | 493.28K | 488.37K | 292.12K | 75.91K | 1.53M | 8.46K | — | — | 11.20K | 38.38K | 37.93K | 16.36K | — | — | — | — | — | — | — |
| Marshall Wace | 560.72K | 95.64K | 1.15M | — | — | — | 18.67K | 37.19K | 116.64K | 81.11K | 76.31K | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 550.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 425.74K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 333.31K | 340.36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 277.06K | 300.70K | 185.51K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AXIOM INVESTORS LLC /DE | 124.20K | 92.11K | 95.75K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 101.02K | 61.56K | 116.72K | 28.46K | 4.46K | 503 | 35.44K | 159.91K | 24.45K | 169.30K | 126.69K | 172.06K | 77.02K | — | — | — | — | — | — | — |
| BNY Mellon | 97.56K | 97.72K | — | — | — | — | — | — | — | — | 104.55K | 108.21K | 108.21K | — | — | — | — | — | — | — |
| Nuveen, LLC | 90.84K | 94.81K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ALPS ADVISORS INC | 78.37K | 55.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold VOR?
As of 2026-Q2, 108 institutional funds reported holding VOR (VOR BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $878.24M.
How many shares of VOR do institutions own?
13F filers reported 47.75M shares of VOR, worth $878.24M in aggregate at the end of 2026-Q2.
Is institutional ownership of VOR rising or falling?
Share counts moved +10.3% versus the prior quarter — accumulation.
Who are the top institutional holders of VOR?
The largest 13F holders are Fidelity Management & Research (FMR), TCG Crossover Management, LLC, FCPM III SERVICES B.V., BlackRock Inc, Venrock Adviser, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of VOR BIOPHARMA INC?
The major shareholders of VOR BIOPHARMA INC (VOR) by reported 13F value are Fidelity Management & Research (FMR), TCG Crossover Management, LLC, FCPM III SERVICES B.V., BlackRock Inc, Venrock Adviser, LLC, among 232 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.